Human Activated Macrophages and Hypoxia: a Comprehensive Review of the Literature

Overview

Journal Iran J Basic Med Sci

Publisher Mashhad University of Medical Sciences

Specialty General Medicine

Date 2015 Feb 19

PMID 25691922

Citations 3

Authors

Fattah Sotoodehnejadnematalahi

Bernard Burke

Affiliations

Soon will be listed here.

Abstract

Macrophages accumulate in poorly vascularised and hypoxic sites including solid tumours, wounds and sites of infection and inflammation where they can be exposed to low levels of oxygen for long periods. Up to date, different studies have shown that a number of transcription factors are activated by hypoxia which in turn activate a broad array of mitogenic, pro-invasive, pro-angiogenic, and pro-metastatic genes. On the other hand, macrophages respond to hypoxia by up-regulating several genes which are chief factors in angiogenesis and tumorigenesis. Therefore, in this review article we focus mainly on the role of macrophages during inflammation and discuss their response to hypoxia by regulating a diverse array of transcription factors. We also review the existing literatures on hypoxia and its cellular and molecular mechanism which mediates macrophages activation.

Citing Articles

Predictive model of gene expression regulating invasion and migration of M2 macrophages in breast cancer: clinical prognosis and therapeutic implications.

Jiang C, Luo J, Jiang X, Lv Y, Dou J Transl Cancer Res. 2024; 13(8):4187-4204.

PMID: 39262492 PMC: 11384920. DOI: 10.21037/tcr-24-29.

Regulatory sequence analysis of semaphorin 4D 5' non-coding region.

Qiu L, Jiang H, Luo J, Xi J, Wang X, Pan Y J Cancer. 2019; 10(4):903-910.

PMID: 30854096 PMC: 6400819. DOI: 10.7150/jca.28169.

Recent perspectives on the delivery of biologics to back of the eye.

Joseph M, Trinh H, Cholkar K, Pal D, Mitra A Expert Opin Drug Deliv. 2016; 14(5):631-645.

PMID: 27573097 PMC: 5570518. DOI: 10.1080/17425247.2016.1227783.

References

Breuer W, Ermers M, Pootrakul P, Abramov A, Hershko C, Cabantchik Z . Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy. Blood. 2001; 97(3):792-8. DOI: 10.1182/blood.v97.3.792. View

Edwards J, Zhang X, Frauwirth K, Mosser D . Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol. 2006; 80(6):1298-307. PMC: 2642590. DOI: 10.1189/jlb.0406249. View

Semenza G . Oxygen homeostasis. Wiley Interdiscip Rev Syst Biol Med. 2010; 2(3):336-361. DOI: 10.1002/wsbm.69. View

Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733):271-5. DOI: 10.1038/20459. View

Negus R, Stamp G, Hadley J, Balkwill F . Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol. 1997; 150(5):1723-34. PMC: 1858213. View

Jurgensen J, Rosenberger C, Wiesener M, Warnecke C, Horstrup J, Grafe M . Persistent induction of HIF-1alpha and -2alpha in cardiomyocytes and stromal cells of ischemic myocardium. FASEB J. 2004; 18(12):1415-7. DOI: 10.1096/fj.04-1605fje. View

Semenza G, Jiang B, Leung S, Passantino R, Concordet J, Maire P . Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem. 1996; 271(51):32529-37. DOI: 10.1074/jbc.271.51.32529. View

Jewell U, Kvietikova I, Scheid A, Bauer C, Wenger R, Gassmann M . Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J. 2001; 15(7):1312-4. View

Ghezzi P, Dinarello C, Bianchi M, Rosandich M, Repine J, White C . Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine. 1991; 3(3):189-94. DOI: 10.1016/1043-4666(91)90015-6. View

10.

Jaakkola P, Mole D, Tian Y, Wilson M, Gielbert J, Gaskell S . Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001; 292(5516):468-72. DOI: 10.1126/science.1059796. View

11.

Ricardo S, Goor H, Eddy A . Macrophage diversity in renal injury and repair. J Clin Invest. 2008; 118(11):3522-30. PMC: 2575702. DOI: 10.1172/JCI36150. View

12.

Vaupel P, Mayer A . Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007; 26(2):225-39. DOI: 10.1007/s10555-007-9055-1. View

13.

Cockman M, Webb J, Ratcliffe P . FIH-dependent asparaginyl hydroxylation of ankyrin repeat domain-containing proteins. Ann N Y Acad Sci. 2009; 1177:9-18. DOI: 10.1111/j.1749-6632.2009.05042.x. View

14.

Benizri E, Ginouves A, Berra E . The magic of the hypoxia-signaling cascade. Cell Mol Life Sci. 2008; 65(7-8):1133-49. PMC: 11131810. DOI: 10.1007/s00018-008-7472-0. View

15.

Greijer A, van der Groep P, Kemming D, Shvarts A, Semenza G, Meijer G . Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol. 2005; 206(3):291-304. DOI: 10.1002/path.1778. View

16.

Van Ginderachter J, Movahedi K, Hassanzadeh Ghassabeh G, Meerschaut S, Beschin A, Raes G . Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology. 2006; 211(6-8):487-501. DOI: 10.1016/j.imbio.2006.06.002. View

17.

Jiang B, Zheng J, Leung S, Roe R, Semenza G . Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J Biol Chem. 1997; 272(31):19253-60. DOI: 10.1074/jbc.272.31.19253. View

18.

Gordon S . The role of the macrophage in immune regulation. Res Immunol. 1998; 149(7-8):685-8. DOI: 10.1016/s0923-2494(99)80039-x. View

19.

Goerdt S, Orfanos C . Other functions, other genes: alternative activation of antigen-presenting cells. Immunity. 1999; 10(2):137-42. DOI: 10.1016/s1074-7613(00)80014-x. View

20.

Hajjar A, Ernst R, Tsai J, Wilson C, Miller S . Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol. 2002; 3(4):354-9. DOI: 10.1038/ni777. View